University of Innsbruck-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2021

  1. The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study

    Leukemia and Lymphoma